Select your timezone:

E-Poster on Display
Poster Session - Liver/Intestine

Presentations

Dr. Megan A Adams, United States
Spontaneous Portosystemic Shunt Ligation During Pediatric Liver Transplantation

Dr. Denise Aldrian, Austria
Sequential liver and hematopoietic stem cell transplantation in a child with erythropoietic protoporphyria: a case report

Dr. Ane M Andres, Spain
Long-term nutritional status in Pediatric Small Bowel Transplantation

Dr. Michael Borchetta, United States
Retrospective analysis investigating the incidence of infection and rejection in relation to the timing of blood product administration in pediatric liver transplant patients

Dr. Rebecca Brocks, Canada
Correlation of activated partial thromboplastin time versus anti-Xa levels for unfractionated heparin monitoring in postoperative pediatric liver transplant patients

Dr. Srinath Chinnakotla, United States
Long term outcomes of liver transplantation for metabolic defects. A single center report

Dr. Serena Abbate, Italy
Multi-faceted peri-transplant strategy for biliary atresia candidates for liver transplantation; effect on access to transplantation and outcome

Dr. Marcos E Pozo, United States
Splenic artery aneurysms in children with cirrhosis and portal hypertension: risk factors and treatment strategies

Ms. Danielle Romero, United States
Carfilzomib desensitization for antibody-mediated rejection in a pediatric liver transplant recipient

Mr. Javier Serradilla, Spain
Indications for liver or multivisceral transplantation: a diffuse borderline

Leanna Shea, United States
Stumbling in the dark: A late presentation of vitamin A deficiency in a pediatric multivisceral transplant patient

Dr. Su young Hong, Korea
Favorable Long-term Renal Outcome following Pediatric Liver Transplantation

Dr. Kyong Ihn, Korea
Postoperative bacteremia is associated with early vascular complications in pediatric liver transplant recipients with biliary atresia

Dr. Noël Knops, Belgium
A longitudinal study on the long term renal outcome of children after liver transplantation in relation to tacrolimus exposure and their pharmacogenetic background

Dr. Chandrashekhar A Kubal, United States
Whole Liver Transplantation with Significant Donor-Recipient Size Mismatch: Role of Objective Assessment

Dr. Ane M Andres, Spain
Effectiveness of antibody-removal therapy in pediatric intestinal transplant recipients

Dr. Emre Karakaya, Turkey
Assessment of Long-term Outcomes of Pediatric Liver Transplant Recipients

Dr. Eberhard Lurz, Germany
CNI free Immunosuppression with Everolimus in children post liver transplantation: A retrospective pilot study.

Miss Ivone Malla, Argentina
Liver transplantation for hepatic epithelioid hemangioendothelioma with lung metastases in a pediatric patient

Miss Rita Marchante Pita, Portugal
Impact of COVID-19 on liver transplant recipients: the experience of a pediatric liver transplantation unit

Hanh D. Vo, United States
Characteristics of de novo autoimmune hepatitis in pediatric liver-small bowel transplant recipients

Xin-yue Wang, People's Republic of China
Timing and Effect of Liver Transplantation in Five Patients with Primary Hyperoxaluria Type 1: A Retrospective Review 

Dr. Dor Yoeli, United States
Plasma galectin-3 is predictive of post-transplant infection in pediatric liver transplant recipients

Haosu Zhan, People's Republic of China
Five cases of familial hypercholesterolemia treated by liver transplantation